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In  the  mouse,  two  sets  of determinants  induce  strong  T  cell  proliferative 
responses in  primary  mixed  lymphocyte culture:  allogeneic  H-2  determinants 
encoded by genes of the  major histocompatibility  complex  (MHC) located on 
chromosome 17, and determinants encoded by the minor lymphocyte stimulating 
(Mls) locus on chromosome  1 (1).  Unlike MHC molecules, Mls determinants are 
undetectable serologically, do not evoke typical transplantation reactions, do not 
appear to act as targets for cytotoxic T cells, and show only limited polymorphism 
(reviewed in  2).  Of the determinants  of the four described Mls  alleles, a,  b,  c, 
and d, only MIs  a and Mls  d determinants elicit strong responses; these two sets of 
determinants  cross-react extensively, and,  indeed,  are  indistinguishable  in  our 
hands. In contrast to conventional antigen, T  cell responses to Mls determinants 
do not exhibit classic H-2 restriction (2). 
Recently (2), we reported that Mlsa'd-specific T cell clones concomitantly display 
apparently random specificity for allo-H-2 determinants.  Given this, and the odd 
properties of Mls determinants (see above), we suggested that T  cell recognition 
of these determinants  might be controlled by a  separate set of receptors, unre- 
lated to the receptors that recognize conventional antigens (self plus X) or allo- 
H-2  antigens.  In  support  of this,  we  show  that  T  cell  hybridomas  with  dual 
reactivity for MIs  a'd and allo-H-2 can lose reactivity to allo-H-2 while retaining 
reactivity  to  Mis  a'd, and  vice  versa.  Thus,  receptors  for  Mls  ~'d  and  allo-H-2 
determinants are probably encoded on different chromosomes. 
Materials and Methods 
Mice.  BALB/c, B10.D2,  DBA/2,  CBA/J,  and  B10.BR  mice were all obtained from 
The Jackson Laboratory, Bar Harbor, ME. B10.RPD2  mice were purchased through Dr. 
Chella David, Mayo Clinic. B10.P mice were provided by Dr. J. Stimpfling,  McLaughlan 
Research Institute and Dr. D. Sachs, National  Institutes  of Health. 
T Cell Clones.  T  cell clones displaying dual reactivity  for Mls and H-2 were derived 
and characterized as previously  described (2). Briefly, B10.D2 (H-2 a, Mlsb~ lymph node 
(LN) cells were stimulated in vitro with irradiated (3,000 rad) DBA/2 (H-2", Mls ~) spleen 
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cells.  14 d later the viable cells were restimulated with irradiated DBA/2 spleen cells; 24 
h later they were cloned at limiting dilution in flat-bottom microtiter plates containing 5 
×  105 irradiated B10.RPD2 (LA  p, Mls ~) spleen cells. The clones were expanded at 2-wk 
intervals in culture medium (RPMI 1640 plus 10% fetal calf  serum) containing supernatant 
(SN) from 36-h concanavalin A (Con A)-stimulated rat spleen cell cultures. DlO.2, the T 
cell clone used to generate one set of hybridomas (see below), proliferates in response to 
all  Mlsa'a-positive  strains  tested,  including  DBA/2,  CBA/J,  NZB,  AKR/J,  D1.LP,  and 
SM/J. The clone has alloreactivity to H-2  p but does not respond to cells from any of nine 
ad  MIs • -negative strains tested of various H-2 haplotypes and backgrounds. 
Fluorescence-activated Cell Sorter (FACS) Analysis.  Viable hybridoma cells  were incu- 
bated with culture supernatant of the GKI.5 B cell hybridoma (3) (provided by F. Fitch, 
University of Chicago) and  then  with  fluorescein isothiocyanate (FITC)-F(ab')2 sheep 
anti-rat Ig (Cappel Laboratories, Cochranville, PA) reagent. The cells were analyzed on 
a  FACS  IV  (B-D  FACS  Systems,  Sunnyvale, CA)  by Dr.  Alan  Pickard,  University of 
Pennsylvania. 
T Cell Hybridomas.  The T  cell hybridoma FS 11.155 was prepared by fusion of Con 
A-stimulated T  cell blasts  from a B10.Q (H-2 q, Mls b) mouse spleen to the T  cell tumor, 
BW5147, by previously described methods (4). This hybridoma responded to spleen cells 
from all Mlsa'd-positive strains tested (DBA/2, CBA/J, NZB, AKR/J, D1.LP, and SM/J). 
The second hybridoma described, BD10.42, was the product of a  fusion of the T  cell 
clone, DI0.2  (described above), to BW5147  using the same procedures. Subclones of 
hybridomas were prepared by recloning at limiting dilution. 
Interleukin  2 (IL-2)Assay.  Using standard procedures (4), hybridomas (1-2 ×  105 cells) 
were assayed for their ability to produce IL-2 when stimulated with 5 ×  l0  s irradiated 
(1,500 rad) spleen cells bearing the appropriate MHC or Mls haplotype. 24-48 h  later, 
100 #l of medium was removed and added to 100 #l medium containing 4,000 HT.2 cells 
(5) or CTLL-2-15H cells (derived originally by Drs.  P.  Baker, S.  Gillis, and K. Smith, 
Dartmouth Medical School); we used these only once (line  1 of Table I).  The cultures 
were pulsed 24 h later with [SH]thymidine, harvested, and counted 18 h afterwards. With 
a 1:4 dilution of rat Con A SN, HT-2 or CTLL cells incorporated 60,000-100,000 cpm. 
Cultured alone, these indicator cells took up <500 cpm. 
Results 
Experimental  Approach.  T  cell  hybridomas  are  karyotypicaily unstable  and 
lose chromosomes for some period  of the  time after fusion  (6).  Hence, if the 
recognition structures for T  cell responses to Mls and  H-2 determinants  were 
encoded on the same  chromosome, then  loss of reactivity to Mls determinants 
by chromosome loss should also be accompanied by loss of H-2 responsiveness, 
and vice versa. Conversely, if these receptor structures were encoded on different 
chromosomes, then some hybridoma clones should show Mls reactivity but lack 
H-2 reactivity, and vice versa. 
To test these predictions we prepared two different T  cell hybridomas with 
dual  specificity  for  Mls  a'a  and  allo-H-2  determinants.  The  hybridomas  were 
repeatedly subcloned by limiting dilution. After each round of cloning 30-100 
hybrids were tested for their ability to secrete IL-2 when triggered with Mls- or 
with H-2-disparate stimulator cells. 
Loss of Mls Reactivity.  The first hybridoma, FS 11.155, showed strong reactiv- 
ity in  IL-2 assays  to  H-2  d stimulators  and  weaker,  but significant  responses  to 
Mls  a'a stimulators (Table I). Subclones of this hybridoma showed three different 
reactivity patterns, represented in Table I. Some (e.g., FS 11.155.14) responded 
well to both MIs  ~'a and H-2 a, some (e.g.,  FS11.155.16) responded only to H-2  a 
but lacked reactivity to Mls  a'a (Table I), and others (e.g.,  FS11.155.12) reacted 
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TABLE  I 
Specificity of Subclones of Dual-reactive Hybridoma FS I I. 155 in 
IL-2 Assay 
Hybridoma 
Stimulators 
BI0.BR  CBA/J  B10.D2 
(H-2 k  , MIs  b)  (H-2 k  , MIs  d  )  (H-2  d  , MIs  b) 
cpm 
FS11.155  496  1,149  14,025 
FSI 1.155.14"  261  29,232  28,825 
FS11.155.12"  198  111  308 
FS 11.155.16*  226  229  16,438 
For details of IL-2 assay, see Materials and Methods. 
* Subclones were picked from limiting dilution plates that had 36 out of 
96 wells positive for growth. 
TABLE  II 
Specificity of Subclones of FS11.155.14 in IL-2 Assay 
Subclone* 
Stimulators 
B 10.BR  CBA]J  BALB/c 
(H-2  k  , Mls  b)  (H-2 k  , Mls  a)  (H-2  d  , Mls  b  ) 
cpm 
FSI 1.155.14.7  98  33,364  24,194 
FS11.155.14.23  667  237  277 
FS11.155.14.37  240  155  20,369 
See Table I. 
* Subclones shown were picked from plates that had  24 out of 96 wells 
positive for growth. 
The dual-reactive hybridoma clone FS 11.155.14 was further subcloned; 23 of 
39 subclones maintained dual reactivity for Mls and H-2, four of 39 lacked both 
reactivities,  and  10  of 39  could  be  stimulated  only  with  H-2  d  stimulators. ~ 
Representative subclones of these three groups are described in Table II. Fig.  1 
summarizes the results obtained with cloning of the FS11.155 hybridoma. Two 
points seem evident: (a) the proportion of subclones showing only H-2 responses 
dropped from -50%  (15/33) in the first round of cloning to 5% (3/65) in the 
third round; while (b) the proportion of dual-reactive clones increased from 50% 
(14133)  to  ~85%  (54/65).  Evidently, the  FSl1.155  hybridoma became more 
stable karyotypically during the process of sequential subcloning. 
Loss of H-2 Reactivity.  The second hybridoma, BD10.42,  was obtained from 
a fusion of BW5147  with a  T  cell clone, D10.2, expressing dual specificity for 
MIs  a'd and H-2  p (Materials and Methods). At the time of fusion, D 10.2 (a subclone 
of parental  clone D10)  was  further subcloned; all  20  subclones showed dual 
reactivity for Mls  a'd and H-2  p. After fusion, the hybridoma BD10 proved to be 
so unstable that three rounds of sequential subcloning were required to derive a 
definitive assessment of specificity in IL-2 assays. Typical specificity patterns that 
emerged after these repeated subclonings are shown in Table III. Many of the 
Two further subclones gave low responses to H-2  d and no response to Mls  a'd. Little emphasis can 
be placed on these findings, however, because further subcloning yielded hybridomas that were all 
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FSl1.155 
,  I  , 
H-2  +,  MIs  -  H-2  ÷,  MIs  ÷  H-2  -,  MIs  - 
(15/33)  (14/33)  (4/33) 
,  I  , 
H-2  ÷,  MIs  -  H-2  +,  MIs  ÷  H-2  -,  MIs  - 
(10/39)  (23/39)  (4/39) 
,  ]  , 
H-2  +,  MIs -  H-2  +,  MIs  +  H.2  -,  MIs  - 
(3/65)  (54/65)  (5/65) 
1st Subcloning 
2nd Subcloning 
3rd Subcloning 
FIGURE  1.  The data summarizes the specificity patterns observed after repeated subcloning 
d  ad  of the H-2 , Mls ' -reactive hybridoma FS 11.155. After each round of subcloning, hybridomas 
retaining dual specificity for  H-2  d and Mls  a'd were further subcloned. Two subclones in the 
second  round of subcloning and three  hybridomas  in the  third  round were  not easy to 
categorize, and have been omitted from the data presented. 
TABLE  III 
Reactivity Patterns of BD l O.4  2 Subclones in IL-2 Assay 
Stimulators 
Exp.  Hybridomas  B 10. BR  CBA/J  B 10.P 
(H-2  k  , Mls  b)  (H-2  k  , MIs  d)  (H-2P,  Mls  b) 
cp~?/ 
1  BD10.42.20.65  386  26,762  4,285 
BD10.42.9.5.7  76  47,500  45 
BD10.42.9.5.7"  40  28,472  81 
.8  117  7,447  44 
.9  43  13,355  96 
.10  49  22,336  55 
.11  37  18,681  56 
FDI3.4.3.11a3  g  116  29,646  16,600 
See Table I. 
* Subclones were picked from plates that had 18 out of 96 wells positive for growth. 
The other subclones tested had a similar reactivity pattern. 
at FD 13,4.3. I la3 is an independently  derived T cell hybridoma used in this experiment 
as a positive control for the B10.P stimulator cells. 
subclones  (e.g.,  BD10.42.20.65)  reacted  with  both  Mls  a'd  and  H-2  p.  Others 
responded to neither stimulator (not shown).  Some,  like BD10.42.9.5,  showed 
no reactivity to  H-2  p and strong reactivity to  Mlsa'a; the specificity patterns of 
five representative subclones derived from BD 10.42.9.5 are shown in Table I II. 
The clones exemplified in Table III showed the same specificity pattern in four 
separate experiments performed over a  6-mo period. 
Expression  of the  L3T4 Marker.  The  mouse  T  cell  surface  molecule L3T4, 
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the avidity with which T  cells react with antigen (7).  It was therefore of interest 
to know whether the loss of only one of the two antigen  specificities by the T 
hybridomas would correlate  with the loss of the  L3T4 molecule.  No evidence 
could be found for such an association. Both sets of hybridomas (FS11.155 and 
BD10.42) were initially L3T4 +, as assessed by FACS analysis with the antibody 
GK1.5  (data not shown). All of the BD10.42-derived hybridomas retained  the 
expression of L3T4, despite repeated subcloning. In marked contrast, all of the 
FS 11.155-derived hybridomas were negative for L3T4 after the third subclon- 
ing, irrespective of their specificity. Loss of the L3T4 marker is thus an unlikely 
explanation for the above results. 
Discussion 
Using karyotypically unstable  T  cell  hybridomas,  we demonstrate  here  that 
dual-reactive hybridomas specific for MIs  a'a and allo-H-2 determinants  generate 
variants which no longer respond to one of these sets of stimulating determinants, 
but  continue  to  respond  to  the  other  set.  The  simplest  explanation  for  this 
observation is that Mls and H-2 determinants are recognized by different sets of 
receptor structures, encoded on different chromosomes. In this case, loss of the 
chromosome  that  encodes  receptors  with  anti-MIs  reactivity would not  affect 
anti-H-2 reactivity, and vice versa. 
Alternatively,  one  could postulate  some mutational  event  that  modifies the 
receptor only slightly,  such  that  it  will  still  react  with  one  ligand  but  not the 
other.  This  mutation  would have  to have  several  unusual  characteristics.  For 
example, it would have to occur with an  unusually high  frequency during  the 
first  1-2  mo  after  fusion,  since  each  round  of subcloning  during  this  time 
generated  a  significant  proportion  of new  clones  lacking  one  reactivity.  The 
mechanism  operative in  generating  such mutations  would then  cease within  a 
few months after fusion,  since after this time we were rarely able to find new 
clones lacking one reactivity. The majority of the subclones obtained from late 
cloning rounds either maintained both reactivities or lost both. Those which lost 
both reactivities were rather frequent, perhaps reflecting defective synthesis or 
secretion of IL-2. Dual-reactive hybridomas derived soon after fusion often show 
reactivity patterns  in which there is high  reactivity to one set of determinants, 
and  intermediate  or  low  reactivity  to  the  other  (e.g.,  FSl1.155  in  Table  I). 
Although such findings are clearly suggestive of mutation,  to date, all attempts 
to obtain  stable hybrids with this specificity have failed.  In our hands,  further 
subcloning of the hybridomas invariably generates a  mixture  of two reactivity 
patterns  (in  addition  to nonreactive  hybridomas):  some hybridomas show high 
reactivity to both sets of determinants,  while others react only to one and  not 
the other sets of determinants (see Table I). 
For the above reasons, and because of the current lack of evidence for somatic 
mutation  in  T  cell receptors (8), chromosome loss would seem to be the most 
likely explanation for the data. Mutations certainly cannot be ruled out, however, 
and it is quite possible that chromosome loss and/or somatic mutation occur. A 
clear distinction between the above two explanations must await a more detailed 
characterization of T  cell receptors at the molecular level. 
One question raised by these results is why only loss of Mls reactivity occurred 
with the FS11.155 hybridoma and only H-2 reactivity was lost with the BD10.42 
hybridoma.  This  result  may indicate  the  occurrence  of predisposing  chromo- 274  WEBB ET  AL.  BRIEF  DEFINITIVE REPORT 
somal events in the immediate postfusion period that dictate which chromosomes 
can be  subsequently lost without compromising the viability of the cell, or its 
capacity to synthesize and secrete IL-2. 
If recognition of Mls determinants is indeed controlled by a  separate set of 
receptors,  what  is  the  biological  significance  of Mls  determinants?  Although 
several possibilities have been suggested (9,  10), our current view is that, since 
Mls  molecules are  expressed  predominantly on  B  cells,  Mls  molecules  might 
function as accessory structures  on B  cells, increasing the overall avidity of T 
cells reactive with antigen on these cells, or perhaps allowing the production of 
a  B cell lymphokine. 
Summary 
Previous  studies  have  shown  that  T  cell  clones  specific  for  strong  Mls  a'd 
determinants  concomitantly display  apparently  random  reactivity  to  allo-H-2 
determinants. One explanation for this finding is that T  cell recognition of Mls  a'd 
and allo-H-2  determinants is controlled by separate  sets of receptors.  If these 
receptors were chromosomally unlinked, karyotypically unstable T  cell hybrids 
with  dual  reactivity for  Mls  a'd and particular  allo-H-2  determinants  would be 
expected, occasionally, to lose reactivity for one set of determinants, but not the 
other. The results presented here provide direct support for this prediction. 
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